96182-53-5 (硫代膦酸 O-[2-(1,1-二甲基乙基)-5-嘧啶基] O-乙酯 O-(1-甲基乙基)酯,Tebupirimfos)

CAS号:
96182-53-5
中文名称:
硫代膦酸 O-[2-(1,1-二甲基乙基)-5-嘧啶基] O-乙酯 O-(1-甲基乙基)酯
英文名称:
Tebupirimfos
安全信息:
分子式:
C13H23N2O3PS
分子量:
318.372082948685

硫代膦酸 O-[2-(1,1-二甲基乙基)-5-嘧啶基] O-乙酯 O-(1-甲基乙基)酯(96182-53-5)名称与标识符

名称

中文别名:
丁基嘧啶磷;丁基嘧啶磷 标准品;丁嘧硫磷 标准品;硫代膦酸 O-[2-(1,1-二甲基乙基)-5-嘧啶基] O-乙酯 O-(1-甲基乙基)酯;
英文别名:
Phosphorothioic acid,O-[2-(1,1-dimethylethyl)-5-pyrimidinyl] O-ethyl O-(1-methylethyl) ester;Tebupirimfos;(2-tert-butylpyrimidin-5-yl)oxy-ethoxy-propan-2-yloxy-sulfanylidene-λ<sup>5</sup>-phosphane;(RS)-[O-(2-TERT-BUTYLPYRIMIDIN-5-YL) O-ETHYL O-ISOPROPYL PHOSPHOROTHIOATE];O-(2-(tert-Butyl)pyrimidin-5-yl) O-ethyl O-isopropyl phosphorothioate;Tebupirimfos Solution;(Ξ)-[O-(2-tert-butylpyrimidin-5-yl) O-ethyl O-propan-2-yl phosphorothioate];BAY-MAT 7484;MAT 7484;O-[2-(1,1-dimethylethyl)-5-pyrimidinyl] O-ethyl O-(1-methylethyl) phosphorothioate;Phostebupirim;Tebupirimphos;Phosphorothioic acid O-[2-(tert-butyl)-5-pyrimidinyl] O-ethyl O-(1-methylethyl) ester;

标识符

MDL:
MFCD01742641
InChIKey:
AWYOMXWDGWUJHS-UHFFFAOYSA-N
Inchi:
1S/C13H23N2O3PS/c1-7-16-19(20,17-10(2)3)18-11-8-14-12(15-9-11)13(4,5)6/h8-10H,7H2,1-6H3
SMILES:
S=P(OC(C)C)(OCC)OC1C=NC(C(C)(C)C)=NC=1

硫代膦酸 O-[2-(1,1-二甲基乙基)-5-嘧啶基] O-乙酯 O-(1-甲基乙基)酯(96182-53-5)物化性质

实验特性

  • LogP : 4.48950
  • PSA : 95.37000
  • 沸点 : 359 ºC
  • 蒸气压 : 0.0±0.8 mmHg at 25°C
  • 闪点 : 171 ºC
  • 颜色与性状 : No data avaiable
  • 密度 : 1.146

计算特性

  • 精确分子量 : 318.11700
  • 氢键供体数量 : 0
  • 氢键受体数量 : 5
  • 可旋转化学键数量 : 7
  • 重原子数量 : 20

硫代膦酸 O-[2-(1,1-二甲基乙基)-5-嘧啶基] O-乙酯 O-(1-甲基乙基)酯(96182-53-5)安全信息

硫代膦酸 O-[2-(1,1-二甲基乙基)-5-嘧啶基] O-乙酯 O-(1-甲基乙基)酯(96182-53-5)海关数据

海关编码:
2933599012
海关数据:

中国海关编码:

2933599012

硫代膦酸 O-[2-(1,1-二甲基乙基)-5-嘧啶基] O-乙酯 O-(1-甲基乙基)酯(96182-53-5)推荐厂家 更多厂家(24)

公司名称 手机号/电话 联系人 QQ 微信 询单
湖北鑫红利化工有限公司 15172537016
027-59503710
吕经理 1018283355
询单
上海源叶生物科技有限公司 15026964105
15026964105
汤思磊 2881489226
询单
湖北摆渡化学有限公司 13517219350
13517219350
彭星 1400878899
询单
湖北扬信医药科技有限公司 18672002673
0714-3996388
童飞 3003335020
询单
湖北成海化工有限公司 13986212397
027-59220433
张思胧 1400858822
询单
巨胜化学研究院 18064118002
027-59599240
陈盼 1400838822
询单
湖北巨胜科技有限公司 18871490354 王珊 1400848866
询单
湖北广奥生物科技有限公司 13657291602
13657291602
郭银 1098480033
询单
湖北信康医药化工有限公司 13476235517
13476235517
杨彩云 1438280055
询单
湖北实顺生物科技有限公司 15107128801
15107128801
郑雨晗 1400818899
询单

硫代膦酸 O-[2-(1,1-二甲基乙基)-5-嘧啶基] O-乙酯 O-(1-甲基乙基)酯(96182-53-5)合成路线

合成路线:1 步
反应条件:
参考文献:
Process for the production of dialkyl pyrimidylphosphates
, Canada, , ,
合成路线:1 步
参考文献:
Phosphoric acid ester
, Federal Republic of Germany, , ,

硫代膦酸 O-[2-(1,1-二甲基乙基)-5-嘧啶基] O-乙酯 O-(1-甲基乙基)酯(96182-53-5)相关文献

硫代膦酸 O-[2-(1,1-二甲基乙基)-5-嘧啶基] O-乙酯 O-(1-甲基乙基)酯(96182-53-5)参考资料

Reaxys RN:
PubChem CID:

硫代膦酸 O-[2-(1,1-二甲基乙基)-5-嘧啶基] O-乙酯 O-(1-甲基乙基)酯(96182-53-5) MSDS

基础信息


Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
  Product identifiers
    Product name        : Tebupirimfos    
    CAS-No.        : 96182-53-5    
  Relevant identified uses of the substance or mixture and uses advised against
    Identified uses        : Laboratory chemicals, Manufacture of substances    
  
  

Section 2. HAZARDS IDENTIFICATION
  Classification of the substance or mixture
  Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
    Acute toxicity, Inhalation (Category 1)
    Acute toxicity, Dermal (Category 2)
    Acute toxicity, Oral (Category 2)
    Acute aquatic toxicity (Category 1)
  Classification according to EU Directives 67/548/EEC or 1999/45/EC
    Very toxic by inhalation, in contact with skin and if swallowed. Very toxic to aquatic organisms, may cause
    long-term adverse effects in the aquatic environment.
  Label elements
  Labelling according Regulation (EC) No 1272/2008 [CLP]
    Pictogram
    Signal word        Danger    
    Hazard statement(s)
    H300        Fatal if swallowed.    
    H310        Fatal in contact with skin.    
    H330        Fatal if inhaled.    
    H400        Very toxic to aquatic life.    
    Precautionary statement(s)
    P260        Do not breathe dust/ fume/ gas/ mist/ vapours/ spray.    
    P264        Wash hands thoroughly after handling.    
    P273        Avoid release to the environment.    
    P280        Wear protective gloves/ protective clothing.    
    P284        Wear respiratory protection.    
    P302 + P350        IF ON SKIN: Gently wash with plenty of soap and water.    
    Supplemental Hazard        none    
    Statements
  According to European Directive 67/548/EEC as amended.
    Hazard symbol(s)
    R-phrase(s)
    R26/27/28        Very toxic by inhalation, in contact with skin and if swallowed.    
    R50/53        Very toxic to aquatic organisms, may cause long-term adverse effects in    
    the aquatic environment.
    S-phrase(s)
    S28        After contact with skin, wash immediately with plenty of water.    
    S36/37        Wear suitable protective clothing and gloves.    
    S45        In case of accident or if you feel unwell, seek medical advice immediately    
    (show the label where possible).
    S60        This material and its container must be disposed of as hazardous waste.    
    S61        Avoid release to the environment. Refer to special instructions/ Safety    
    data sheets.
    Caution - substance not yet tested completely.
  Other hazards - none

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
  Substances
    Formula        : C13H23N2O3PS    
    Molecular Weight        : 318,37 g/mol    
    Component        Concentration    
  Tebupirimfos
    CAS-No.        96182-53-5        -    

Section 4. FIRST AID MEASURES
  Description of first aid measures
  General advice
    Consult a physician. Show this safety data sheet to the doctor in attendance.
  If inhaled
    If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
  In case of skin contact
    Wash off with soap and plenty of water. Take victim immediately to hospital. Consult a physician.
  In case of eye contact
    Flush eyes with water as a precaution.
  If swallowed
    Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
  Most important symptoms and effects, both acute and delayed
    Cholinesterase inhibitors can cause heavy salivation and secretion in the lungs, lachrymation, blurred
    vision, involuntary defecation, diarrhea, tremor, ataxia, sweating, hypothermia, lowered heart rate, and/or a
    fall in blood pressure as a result of their action at cholinergic nerve sites., Headache, Nausea, Vomiting,
    Dizziness, Drowsiness, Confusion., Weakness, Muscle cramps/spasms., To the best of our knowledge, the
    chemical, physical, and toxicological properties have not been thoroughly investigated.
  Indication of any immediate medical attention and special treatment needed
    no data available

Section 5. FIREFIGHTING MEASURES
  Extinguishing media
  Suitable extinguishing media
    Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
  Special hazards arising from the substance or mixture
    Carbon oxides, nitrogen oxides (NOx), Sulphur oxides, Oxides of phosphorus
  Advice for firefighters
    Wear self contained breathing apparatus for fire fighting if necessary.
  Further information
    no data available

Section 6. ACCIDENTAL RELEASE MEASURES
  Personal precautions, protective equipment and emergency procedures
    Wear respiratory protection. Avoid breathing vapors, mist or gas. Ensure adequate ventilation. Evacuate
    personnel to safe areas.
  Environmental precautions
    Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the
    environment must be avoided.
  Methods and materials for containment and cleaning up
    Soak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed
    containers for disposal.
  Reference to other sections
    For disposal see section 13.

Section 7. HANDLING AND STORAGE
  Precautions for safe handling
    Avoid contact with skin and eyes. Avoid inhalation of vapour or mist.
    Normal measures for preventive fire protection.
  Conditions for safe storage, including any incompatibilities
    Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are
    opened must be carefully resealed and kept upright to prevent leakage.
    Recommended storage temperature: 2 - 8 °C
  Specific end use(s)
    no data available

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
  Control parameters
  Components with workplace control parameters
  Exposure controls
  Appropriate engineering controls
    Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling
    the product.
  Personal protective equipment
  Eye/face protection
    Face shield and safety glasses Use equipment for eye protection tested and approved under
    appropriate government standards such as NIOSH (US) or EN 166(EU).
  Skin protection
    Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
    (without touching glove's outer surface) to avoid skin contact with this product. Dispose of
    contaminated gloves after use in accordance with applicable laws and good laboratory practices.
    Wash and dry hands.
    The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
    the standard EN 374 derived from it.
  Body Protection
    Complete suit protecting against chemicals, The type of protective equipment must be selected
    according to the concentration and amount of the dangerous substance at the specific workplace.
  Respiratory protection
    Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator
    with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup
    to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air
    respirator. Use respirators and components tested and approved under appropriate government
    standards such as NIOSH (US) or CEN (EU).

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
  Information on basic physical and chemical properties
    a) Appearance        Form: liquid    
    Colour: brown
    b) Odour        no data available    
    c) Odour Threshold        no data available    
    d) pH        no data available    
    e) Melting point/freezing        no data available    
    point
    f) Initial boiling point and no data available
    boiling range
    g) Flash point        no data available    
    h) Evaporation rate        no data available    
    i) Flammability (solid, gas) no data available
    j) Upper/lower        no data available    
    flammability or
    explosive limits
    k) Vapour pressure        no data available    
    l) Vapour density        no data available    
    m) Relative density        no data available    
    n) Water solubility        no data available    
    o) Partition coefficient: n- log Pow: 3,8 - 4,6
    octanol/water
    p) Auto-ignition        no data available    
    temperature
    q) Decomposition        no data available    
    temperature
    r) Viscosity        no data available    
    s) Explosive properties        no data available    
    t) Oxidizing properties        no data available    
  Other safety information
    no data available

Section 10. STABILITY AND REACTIVITY
  Reactivity
    no data available
  Chemical stability
    no data available
  Possibility of hazardous reactions
    no data available
  Conditions to avoid
    no data available
  Incompatible materials
    Strong oxidizing agents
  Hazardous decomposition products
    Other decomposition products - no data available

Section 11. TOXICOLOGICAL INFORMATION
  Information on toxicological effects
  Acute toxicity
  Skin corrosion/irritation
    no data available
  Serious eye damage/eye irritation
    no data available
  Respiratory or skin sensitization
    no data available
  Germ cell mutagenicity
    no data available
  Carcinogenicity
    IARC:        No component of this product present at levels greater than or equal to 0.1% is identified as    
    probable, possible or confirmed human carcinogen by IARC.
  Reproductive toxicity
    no data available
  Specific target organ toxicity - single exposure
    no data available
  Specific target organ toxicity - repeated exposure
    no data available
  Aspiration hazard
    no data available
  Potential health effects
  Inhalation        May be fatal if inhaled. May cause respiratory tract irritation.    
  Ingestion
    May be fatal if swallowed.
  Skin        May be fatal if absorbed through skin. May cause skin irritation.    
  Eyes        May cause eye irritation.    
  Signs and Symptoms of Exposure
    Cholinesterase inhibitors can cause heavy salivation and secretion in the lungs, lachrymation, blurred
    vision, involuntary defecation, diarrhea, tremor, ataxia, sweating, hypothermia, lowered heart rate, and/or a
    fall in blood pressure as a result of their action at cholinergic nerve sites., Headache, Nausea, Vomiting,
    Dizziness, Drowsiness, Confusion., Weakness, Muscle cramps/spasms., To the best of our knowledge, the
    chemical, physical, and toxicological properties have not been thoroughly investigated.
  Additional Information
    RTECS: TF8750000

Section 12. ECOLOGICAL INFORMATION
  Toxicity
    Toxicity to fish        LC50 - Lepomis macrochirus (Bluegill) - 0,056 - 0,11 mg/l - 96,0 h    
    Toxicity to daphnia and EC50 - Daphnia magna (Water flea) - < 0,001="" mg/l="" -="" 48="">
    other aquatic
    invertebrates
    Toxicity to algae        EC50 - Desmodesmus subspicatus (green algae) - > 1,8 mg/l - 96 h    
  Persistence and degradability
    no data available
  Bioaccumulative potential
    no data available
  Mobility in soil
    no data available
  Results of PBT and vPvB assessment
    no data available
  Other adverse effects
    Very toxic to aquatic life.

Section 13. DISPOSAL CONSIDERATIONS
  Waste treatment methods
  Product
    Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
    professional waste disposal service to dispose of this material.
  Contaminated packaging
    Dispose of as unused product.

Section 14. TRANSPORT INFORMATION
  UN number
    ADR/RID: 2810        IMDG: 2810        IATA: 2810    
  UN proper shipping name
    ADR/RID: TOXIC LIQUID, ORGANIC, N.O.S. (Tebupirimfos)
    IMDG: TOXIC LIQUID, ORGANIC, N.O.S. (Tebupirimfos)
    IATA:        Toxic liquid, organic, n.o.s. (Tebupirimfos)    
  Transport hazard class(es)
    ADR/RID: 6.1        IMDG: 6.1        IATA: 6.1    
  Packaging group
    ADR/RID: I        IMDG: I        IATA: I    
  Environmental hazards
    ADR/RID: yes        IMDG Marine Pollutant: yes        IATA: no    
  Special precautions for user
    no data available



SECTION 15 - REGULATORY INFORMATION
N/A


SECTION 16 - ADDITIONAL INFORMATION
N/A